Suspended
The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease
What is being collected
Data Collection
Collected from today forward - ProspectiveWho is being recruted
Lung Diseases+4
+ Pulmonary Fibrosis
+ Respiratory Tract Diseases
Over 18 Years
+5 Eligibility Criteria
How is the trial designed
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Observational
Study Start: May 2013
Summary
Principal SponsorMeir Medical Center
Study ContactDavid Shitrit, Dr.More contacts
Last updated: April 9, 2015Sourced from a government-validated database.Claim as a partner
Study start date: May 1, 2013
Actual date on which the first participant was enrolled.We hypothesized that the multi-disciplinary assessment of interstitial lung disease patients would lead to a more accurate diagnosis and consequently alterations in treatment regimens that may lead to improved outcomes.
Principal SponsorMeir Medical Center
Study ContactDavid Shitrit, Dr.More contacts
Last updated: April 9, 2015Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Lung DiseasesPulmonary FibrosisRespiratory Tract DiseasesSkin and Connective Tissue DiseasesConnective Tissue DiseasesLung Diseases, InterstitialIdiopathic Pulmonary Fibrosis
Criteria
3 inclusion criteria required to participate
Age above 18 years old
ILD according to ATS/ERS guidelines
Signed inform consent
2 exclusion criteria prevent from participating
Other significant systemic disease
Previous lung surgery
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Recruiting
SuspendedOne Study Center